Invesaro

Stocks TRS Financial statements

Financial statements

TRIMAS CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data TRIMAS CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue794818705724770857884652631646
Cost of revenue583467505530588640676499501508
Gross profit211189200194182217208153130138
Selling, general and administrative15299.991.2103134122131102110129
Operating income-41.992.710991.2-88.395.199.150.715.241.3
Interest expense13.714.413.91414.714.514.115.919.618
Other non-operating income-16.3-22.8-16.5-13-14.4-26-11.4-14.8-19.4-17
Pre-tax income-58.269.992.478.3-10369.187.735.9-4.1824.3
Income tax-18.433.918.716.3-2311.821.56.31-2.23-48.1
Income from continuing operations-39.83673.761.9-79.857.329.5-1.9572.3
Net income-39.83183.398.6-79.857.366.240.424.3120
EBITDA2.93133149135-38.514915210880.181
EPS, basic-0.880.681.822.18-1.831.331.570.970.602.97
EPS, diluted-0.880.671.802.16-1.831.321.560.970.602.95
Shares, basic (weighted)45.445.745.845.343.64342.241.440.740.4
Shares, diluted (weighted)45.44646.245.643.643.342.541.740.740.8
Dividend per share0.040.040.040.040.04

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents20.727.61081727414111234.923.130
Receivables11211297.2109113126132148116111
Inventory160155127133149152163192110109
Other current assets16.116.16.920.115.11314.82227.336.4
Total current assets309311412434352432423397427463
Property, plant and equipment179190172214253266278330238248
Lease right-of-use assets027.937.850.747.343.232.431.8
Goodwill315319317335304315340294287300
Intangible assets21419416816120619718818178.476.6
Other non-current assets8.48.978.22021.433.62016.19.4145.4
Total assets1,0521,0331,1011,1931,1941,3041,3051,3421,3241,485
Accounts payable72.372.467.472.769.987.885.291.972.472.3
Accrued liabilities47.249.543.94260.55946.759.642.859.6
Short-term debt13.80000
Total current liabilities133122142120137155140159159184
Long-term debt361303294295346394395396398469
Lease liabilities023.131.643.8413829.131.1
Other non-current liabilities51.958.639.240.869.75956.340.642.265.8
Total liabilities552489480495610673653659657779
Total debt379311300300350400400400402473
Paid-in capital818824817783749732696678664578
Retained earnings-294-263-180-79.9-160-102-36.14.2321.7127
Other comprehensive income-24.4-17.3-16.9-6-5.620.23-8.620.65-18.6-0.01
Shareholders' equity500544620697584631652683667706
Total equity500544620697584631652683667706
Total liabilities and equity1,0521,0331,1011,1931,1941,3041,3051,3421,3241,485
Shares outstanding45.545.745.544.643.242.841.741.240.637.6

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income-39.83183.398.6-79.857.366.240.424.3120
Depreciation and amortization44.940.340.543.549.853.553.257.664.939.7
Stock-based compensation6.946.787.176.458.179.59.849.676.9611.5
Deferred income tax-32.215.35.984.44-31.71.49-1.44-4.36-4.23-41.8
Change in receivables7.993.98-9.573.289.58-11.2-6.65-5.52-20.51.78
Change in inventory5.184.62-14.70.743.98-0.96-6.97-7.07-21.2-4.27
Change in payables-18.14.45-2.33-12.84.492.12-29.1-14.50.56-2.36
Cash from operations80.512012975.612713472.688.263.8117
Capital expenditures-31.3-33.7-23.4-29.7-40.5-45.1-46-54.2-51-48.4
Acquisitions000-67.1-194-34.3-64.1-77.30-37.7
Cash from investing-31.1-32.4-24.829.1-232-79.2-55-134-47-64.1
Debt issued030000040000
Debt repaid-13.9-25800
Stock issued0.16
Share buybacks00-12.1-36.7-39.4-19.1-36.9-18.8-19.3-103
Dividends paid00-1.74-6.88-6.7-6.63-6.61
Cash from financing-48.1-80.8-24-40.46.1411.8-46.2-30.9-28.6-46.5
Net change in cash1.266.8780.664.3-98.566.8-28.7-77.2-11.86.95
Free cash flow49.186.410645.986.989.226.63412.869.1
Interest paid11.89.4313.812.413.213.31314.318.718.8
Income taxes paid17.216.27.38449.0610.520.116.811.910.6

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $39.15 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin18.2%Gross profit / revenue.
Operating margin1.3%Operating income / revenue.
EBITDA margin7.1%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin0.7%Pre-tax income / revenue.
Net margin117.9%Net income / revenue.
FCF margin-1.3%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin2.6%Cash from operations / revenue.
Effective tax rate-994.8%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)62.7%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)40.3%Net income / average total assets.
Return on invested capital (ROIC)1.3%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue13.1%Selling, general and administrative expense / revenue.
Stock-based pay / revenue1.6%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue3.9%Capital expenditures / revenue.
D&A / revenue5.7%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y2.4%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-9.9%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y-3.5%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y6.7%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y-12.8%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y-5.4%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y172.2%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y-25.3%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y1.1%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y-19.0%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y395.4%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y22.0%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y391.7%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y23.7%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y84.1%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y17.4%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y-1.6%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y439.0%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y37.4%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y-4.5%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y0.0%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y0.0%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y5.7%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y2.7%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y3.8%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y12.2%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y4.4%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y4.5%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y0.2%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-1.3%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-1.3%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio5.44xCurrent assets / current liabilities.
Quick ratio4.91x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio4.37x(Cash + short-term investments) / current liabilities.
Debt / equity0.28xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets17.7%Total debt / total assets.
Liabilities / assets35.8%Total liabilities / total assets.
Net debt-$845.6MTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA-15.6xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage0.55xOperating income / interest expense.
Working capital$1.26BCurrent assets - current liabilities.
Goodwill and intangibles / assets16.5%(Goodwill + intangible assets) / total assets.
Tangible book value$1.07BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.34xRevenue / average total assets.
Fixed asset turnover3.19xRevenue / average property, plant and equipment.
Inventory turnover3.33xCost of revenue / average inventory.
Days inventory109 days365 x average inventory / cost of revenue.
Receivables turnover5.00xRevenue / average receivables.
Days sales outstanding73 days365 x average receivables / revenue.
Days payables210 days365 x average accounts payable / cost of revenue.
Cash conversion cycle-27 daysDays inventory + days sales outstanding - days payables.
FCF conversion-1.1%Free cash flow / net income, when net income is positive.
Capex / operating cash flow149.4%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$24.03Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$21.20Revenue / diluted weighted shares.
FCF per share-$0.27Free cash flow / diluted weighted shares.
Operating cash flow per share$0.56Cash from operations / diluted weighted shares.
Book value per share$40.22Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$29.91Tangible book value / shares outstanding.
Cash per share$34.64(Cash + short-term investments) / shares outstanding.
Payout ratio0.7%Dividends paid / net income, when net income is positive.

Valuation

MetricValueHow it is calculated
Market cap$1.40BShare price x shares outstanding.
Enterprise value$558.9MMarket cap + total debt - cash - short-term investments.
P/E1.55xMarket cap / net income. Only when net income is positive.
P/S1.83xMarket cap / revenue.
P/B0.97xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book1.31xMarket cap / tangible book value, when positive.
P/OCF69.8xMarket cap / cash from operations, when positive.
EV/Sales0.73xEnterprise value / revenue.
EV/EBIT55.1xEnterprise value / operating income, when both are positive.
EV/EBITDA10.3xEnterprise value / EBITDA, when both are positive.
FCF yield-0.7%Free cash flow / market cap.
Earnings yield64.5%Net income / market cap (the inverse of P/E).
Dividend yield0.4%Dividends paid over the period / market cap.
Shareholder yield12.9%(Dividends paid + share buybacks) / market cap.
PEG0.07xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was TRIMAS CORP's revenue in fiscal 2025?

TRIMAS CORP reported revenue of $645.7M for fiscal 2025, 2.4% higher than the year before.

Was TRIMAS CORP profitable in fiscal 2025?

Yes. Net income was $120.1M, a net margin of 18.6%.

How much free cash flow did TRIMAS CORP generate in fiscal 2025?

Cash from operations of $117.5M minus capital expenditures of $48.4M left free cash flow of $69.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to TRIMAS CORP